Myles Hume, Author at Insight - Page 108 of 119

Thursday, January 22, 2026

No Results

View All Results

No Results

View All Results

Home Author

Myles Hume

Company updates & acquisitions

Novartis pursues PBS listing for Beovu

News

AI predicts treatment outcome for diabetic vision loss

Company updates & acquisitions

Safilo secures digital position acquisition of Blenders

$The study also found the minimum degree of refractive error most practitioners considered necessary to prescribe for was −0.50D.$

Local

Myopia: Spectacles the most common approach for Aussie optometrists

Business

Zeiss At Lisa tri family IOLs satisfy key performance measures

Feature

Myopia, presbyopia and everything in between at ICCLC

Company updates & acquisitions

Specsavers reaches 400-store milestone

Cylite’s HP-OCT featured in the research of two international institutions presented at ARVO in Colorado.

Medical device industry expert joins Aussie OCT company

The new non-surgical treatment for corneal blindness uses a gel-like therapy. Image credit: Tej Kohli Foundation

International

Eye filler therapy shows promise with corneal blindness

February 28, 2020

Novartis states there is no validated new or changed safety signal for Beovu.

Business

Novartis AMD drug Beovu secures European approval

February 28, 2020

Page 108 of 119 Prev 1 … 107 108 109 … 119 Next

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

Popular Topics

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results

View All Results

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited